<bill session="108" type="h" number="2931" updated="2013-07-14T19:01:53-04:00">
  <state datetime="2003-07-25">REFERRED</state>
  <status>
    <introduced datetime="2003-07-25"/>
  </status>
  <introduced datetime="2003-07-25"/>
  <titles>
    <title as="introduced" type="short">Orphan Drug Tax Credit Act of 2003</title>
    <title as="introduced" type="official">To provide for the expansion of human clinical trials qualifying for the orphan drug credit.</title>
  </titles>
  <sponsor id="400046"/>
  <cosponsors>
    <cosponsor id="400256" joined="2003-07-25"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2003-07-25">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Taxation"/>
    <term name="Clinical trials"/>
    <term name="Commerce"/>
    <term name="Drug industry"/>
    <term name="Health"/>
    <term name="Income tax"/>
    <term name="Orphan drugs"/>
    <term name="Pharmaceutical research"/>
    <term name="Research and development tax credit"/>
    <term name="Science, technology, communications"/>
  </subjects>
  <amendments/>
  <summary>7/25/2003--Introduced.
Orphan Drug Tax Credit Act of 2003 - Amends the Internal Revenue Code to move up the date for which a taxpayer may claim the credit for the clinical testing of drugs for rare diseases or conditions (orphan drugs) from the date a drug is designated an orphan drug to the date the application for such designation is filed.</summary>
</bill>
